Literature DB >> 24101732

Prevalence of menstrual migraine: a population-based study.

Kjersti G Vetvik1, E Anne Macgregor, Christofer Lundqvist, Michael B Russell.   

Abstract

AIM: To present data from a population-based epidemiological study on menstrual migraine.
MATERIAL AND METHODS: Altogether, 5000 women aged 30-34 years were screened for menstrual migraine. Women with self-reported menstrual migraine in at least half of their menstrual cycles were invited to an interview and examination. We expanded the International Classification of Headache Disorders III beta appendix criteria on menstrual migraine to include both migraine without aura and migraine with aura, as well as probable menstrual migraine with aura and migraine without aura.
RESULTS: A total of 237 women were included in the study. The prevalence among all women was as follows: any type of menstrual migraine 7.6%; menstrual migraine without aura 6.1%; menstrual migraine with aura 0.6%; probable menstrual migraine without aura 0.6%; probable menstrual migraine with aura 0.3%. The corresponding figures among female migraineurs were: any type of menstrual migraine 22.0%, menstrual migraine without aura 17.6%, menstrual migraine with aura 1.7%, probable menstrual migraine without aura 1.6% and probable menstrual migraine with aura 1.0%.
CONCLUSION: More than one of every five female migraineurs aged 30-34 years have migraine in ≥50% of menstruations. The majority has menstrual migraine without aura and one of eight women had migraine with aura in relation to their menstruation. Our results indicate that the ICHD III beta appendix criteria of menstrual migraine are not exhaustive.

Entities:  

Keywords:  Migraine; classification; menstrual migraine; menstruation; prevalence

Mesh:

Year:  2013        PMID: 24101732     DOI: 10.1177/0333102413507637

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  22 in total

Review 1.  Menstrual migraine: what it is and does it matter?

Authors:  Letizia Maria Cupini; Ilenia Corbelli; Paola Sarchelli
Journal:  J Neurol       Date:  2020-01-28       Impact factor: 4.849

Review 2.  Effects of the Menstrual Cycle on Neurological Disorders.

Authors:  Hannah J Roeder; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

Review 3.  Current Treatment Options: Headache Related to Menopause-Diagnosis and Management.

Authors:  Clinton G Lauritsen; Abigail L Chua; Stephanie J Nahas
Journal:  Curr Treat Options Neurol       Date:  2018-03-06       Impact factor: 3.598

Review 4.  A review of frovatriptan for the treatment of menstrual migraine.

Authors:  E Anne MacGregor
Journal:  Int J Womens Health       Date:  2014-05-21

5.  Menstrual migraines.

Authors:  Franco Granella
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

6.  Genome-wide DNA methylation profiling in whole blood reveals epigenetic signatures associated with migraine.

Authors:  Zachary F Gerring; Allan F McRae; Grant W Montgomery; Dale R Nyholt
Journal:  BMC Genomics       Date:  2018-01-22       Impact factor: 3.969

7.  The chronobiology of migraine: a systematic review.

Authors:  Amanda Holmen Poulsen; Samaira Younis; Janu Thuraiaiyah; Messoud Ashina
Journal:  J Headache Pain       Date:  2021-07-19       Impact factor: 7.277

Review 8.  Acute and Preventive Management of Migraine during Menstruation and Menopause.

Authors:  Raffaele Ornello; Eleonora De Matteis; Chiara Di Felice; Valeria Caponnetto; Francesca Pistoia; Simona Sacco
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

9.  Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura.

Authors:  Kjersti Grøtta Vetvik; E Anne MacGregor; Christofer Lundqvist; Michael Bjørn Russell
Journal:  J Headache Pain       Date:  2014-05-17       Impact factor: 7.277

10.  Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study.

Authors:  Licia Grazzi; Gabriella Egeo; Anne H Calhoun; Candace K McClure; Eric Liebler; Piero Barbanti
Journal:  J Headache Pain       Date:  2016-10-03       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.